Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-21-039808
Filing Date
2021-08-02
Accepted
2021-08-02 16:57:06
Documents
11
Period of Report
2021-05-17
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A rkda-8ka_20210517.htm 8-K/A 41386
2 EX-23.1 rkda-ex231_8.htm EX-23.1 4613
3 EX-23.2 rkda-ex232_9.htm EX-23.2 2562
4 EX-99.1 rkda-ex991_10.htm EX-99.1 315019
5 EX-99.2 rkda-ex992_91.htm EX-99.2 231665
6 EX-99.3 rkda-ex993_11.htm EX-99.3 256286
7 EX-99.4 rkda-ex994_92.htm EX-99.4 188316
8 EX-99.5 rkda-ex995_12.htm EX-99.5 871064
9 GRAPHIC gy4ripl21iac000001.jpg GRAPHIC 1908
10 GRAPHIC gmo5jxvucuie000001.jpg GRAPHIC 7266
11 GRAPHIC gy4ripl21iac000002.jpg GRAPHIC 4213
  Complete submission text file 0001564590-21-039808.txt   1930897
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37383 | Film No.: 211136758
SIC: 0100 Agricultural Production-Crops